ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery is a prestigious peer-reviewed journal, published by KARGER, dedicated to advancing the field of otorhinolaryngology. With a rich history dating back to 1938, this journal addresses crucial developments in the diagnosis and treatment of disorders affecting the ear, nose, throat, and related structures of the head and neck. As per the 2023 Scopus rankings, it holds a commendable position of Q3 in the otorhinolaryngology category, showcasing its relevance and contribution to medical research. Currently indexed with an ISSN of 0301-1569 and an E-ISSN of 1423-0275, the journal fosters an academic environment for researchers, practitioners, and students to share their findings, case studies, and reviews. Although it operates on a traditional subscription model, its significant impact on the field makes it an essential resource for enhancing knowledge and practice in head and neck surgery. By encouraging rigorous research, ORL remains at the forefront of otorhinolaryngology, addressing the ever-evolving challenges and innovations in this dynamic medical specialty.

Journal of Otolaryngology-Head & Neck Surgery, published by SAGE Publications Inc, stands at the forefront of research in the fields of otorhinolaryngology and surgery. With an impressive Q1 ranking in both categories, this open-access journal, available since 2013, facilitates the dissemination of cutting-edge findings that enhance our understanding of complex head and neck disorders. Situated in the United Kingdom, the journal provides a vital platform for researchers, clinicians, and students to contribute to and engage with innovative therapeutic strategies and surgical techniques. The impact factor, underscored by its robust placement in Scopus rankings—7th among 123 in otorhinolaryngology and 35th among 551 in surgery—reflects its critical role in advancing evidence-based practice and informing clinical decisions globally. Covering a wide array of topics from basic science to practical implications, the journal is committed to fostering a collaborative and dynamic research environment.

Urogynecology, published by Lippincott Williams & Wilkins, is a distinguished journal that serves as an essential platform for researchers, clinicians, and students in the fields of obstetrics, gynecology, surgery, and urology. With an impact factor that places it in the Q2 category in various specialties, the journal emphasizes high-quality, peer-reviewed research that contributes to advancements in women's health and pelvic floor disorders. As an Open Access journal, it is committed to enhancing the accessibility of its content, allowing for broader dissemination of knowledge and fostering collaborative efforts in the medical community. Located in India and addressing a global audience, Urogynecology has quickly established its reputation since its inception in 2022, continuing through its converged years until 2024. It is ranked favorably in Scopus across several medical categories, providing a vital resource for cutting-edge research and clinical practice insights. This journal aims to bridge gaps in knowledge and practice, making it an invaluable asset for anyone dedicated to improving outcomes in urogynecology.

Acta Otorrinolaringologica Espanola, published by Elsevier Espana SLU, is a leading journal in the field of Otorhinolaryngology, dedicated to advancing the understanding and treatment of ear, nose, and throat disorders. With a history dating back to 1973 and an established reputation for rigorously peer-reviewed research, this journal plays a pivotal role in disseminating significant findings to both clinicians and researchers. Although it is currently categorized in the Q3 quartile for 2023, ranking 72 out of 123 in its field, it serves as a vital platform for the exploration of innovative concepts and clinical practices, contributing to a deeper understanding of otolaryngological issues. While the journal is not open access, it continues to attract a wide readership due to its comprehensive articles and impactful studies. Positioned in Barcelona, Spain, this journal provides a critical resource for professionals and scholars aiming to enhance their knowledge and improve clinical outcomes in Otorhinolaryngology.

Acta Otorhinolaryngologica Italica is a prestigious peer-reviewed journal published by PACINI EDITORE, dedicated to advancing the field of otorhinolaryngology. Since its inception in 1981, the journal has established itself as an essential resource for researchers, clinicians, and students interested in the latest developments in ear, nose, and throat medicine. With an impressive Q2 category ranking in the field of Otorhinolaryngology as per Scopus rankings, the journal maintains a significant presence internationally, ranked #39 out of 123 in its category and placing it in the 68th percentile. Acta Otorhinolaryngologica Italica transitioned to an Open Access model in 2018, ensuring that groundbreaking research is accessible to a broader audience, thus fostering collaboration and innovation across the global medical community. With an ongoing commitment to quality and rigor, this journal serves as a valuable platform for disseminating critical findings, case studies, and reviews that contribute to the enhancement of healthcare practices and patient outcomes in otorhinolaryngology.

Egyptian Journal of Otolaryngology (EJOT) is a premier open access journal dedicated to advancing the field of otorhinolaryngology. Published by Springer, the journal has been an essential resource for researchers and practitioners since its transition to open access in 2012. With an ISSN of 1012-5574 and E-ISSN 2090-8539, EJOT aims to facilitate the dissemination of high-quality research, covering a broad spectrum of topics within otolaryngology. The journal's significance is underscored by its current ranking in the Q3 category of the Scopus Otorhinolaryngology category, and it is positioned in the 23rd percentile of its field, reflecting its commitment to scholarly excellence. Researchers, professionals, and students alike will find valuable insights and innovative studies in the journal's articles, contributing to ongoing education and the advancement of best practices in ear, nose, and throat medicine. The journal is based in Germany with its operations centered at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, UNITED STATES, ensuring a global reach in the academic community.

LARYNGOSCOPE, published by Wiley, is a premier journal in the field of Otorhinolaryngology, boasting an impressive impact factor and ranked #8 out of 123 in its category, placing it in the 93rd percentile among its peers. Since its inception in 1896, the journal has served as a vital platform for disseminating high-quality research, innovative clinical practices, and advancements in the study of ear, nose, and throat diseases. The journal is committed to providing comprehensive coverage of original research, case studies, and reviews that shape the future of Otorhinolaryngology. With a notable Q1 category ranking in 2023, it remains at the forefront of medical publications, making it an essential resource for researchers, health professionals, and students who seek to stay abreast of the latest developments in the field. Although not an Open Access journal, it provides valuable insights that contribute to the understanding and treatment of complex disorders within otolaryngology. The journal’s dedication to excellence ensures its readers receive cutting-edge information that is critical for advancing their work and enhancing patient care.

ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY is a premier peer-reviewed journal published by SAGE Publications Inc, dedicated to advancing research and knowledge in the specialties of otology, rhinology, and laryngology. With a prestigious history dating back to 1897, the journal has established itself as a vital resource for clinicians and researchers in the field, currently classified in the Q2 category for both Medicine (miscellaneous) and Otorhinolaryngology as of 2023. The journal's focus on integrating clinical practice with innovative research findings makes it indispensable for professionals seeking to stay at the forefront of medical advancements. Although it does not offer open access, the journal maintains a strong impact in the scholarly community, ranked #49 out of 123 in Otorhinolaryngology according to Scopus, placing it within the 60th percentile of academic publishing. Researchers, clinicians, and students alike find the ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY an essential platform to disseminate their work and stay informed about the latest developments in their fields.

ENT Updates is a premier open-access journal dedicated to advancing the field of otolaryngology, providing a dynamic platform for the dissemination of cutting-edge research and developments in ear, nose, and throat medicine. Published by AVES, this journal has been accessible to a global audience since its establishment in 2011, ensuring that vital research is freely available to researchers, healthcare professionals, and students alike. With its ISSN 2149-7109 and E-ISSN 2149-6498, ENT Updates emphasizes high-quality, peer-reviewed articles that contribute to the growing body of knowledge in this specialized area of medicine. Readers can expect comprehensive reviews, original research, and clinical studies that are instrumental in shaping contemporary practices in otolaryngology. The journal's commitment to open access fosters collaboration and knowledge sharing, empowering professionals in the field to stay informed and enhance patient care.

The European Journal of Surgical Oncology (EJSO), published by Elsevier Science Ltd, stands as a leading international journal dedicated to the field of surgical oncology. With an ISSN of 0748-7983 and an E-ISSN of 1532-2157, EJSO has been a key resource for researchers and practitioners since its inception in 1985, covering a wide spectrum of topics in advanced surgical techniques, oncology practices, and multidisciplinary approaches to cancer treatment. The journal boasts impressive rankings, being classified in the Q1 quartile for Medicine (Miscellaneous) and Surgery, and Q2 in Oncology for 2023, reflecting its high impact within the scientific community, with a Scopus ranking of #36/551 in Medicine and Surgery, placing it in the 93rd percentile. Although it does not currently offer Open Access options, EJSO remains committed to advancing the field through reliable research and innovative surgical methodologies. Its ongoing contributions are invaluable for those engaged in the continuous improvement of cancer treatment and management.